Create New Share
Please enter the email address below of the person you would like to share this article with.
An email will be sent to the recipient with a link to this chosen article.
A source for healthcare professionals to access the latest data and information on the diagnosis, treatment and management of patients with gut related disorders
Nightingale A. Nurse Prescribing 2007;5:289–296.
Inflammatory bowel disease (IBD)—comprising ulcerative colitis (UC) and Crohn’s disease—is a chronic condition that affects about 1 in 700 people in the UK. Symptoms are variable and are generally related to the site of disease and its severity. Since many conditions can mimic IBD, accurate diagnosis is essential to select the most appropriate and effective treatment.
Treatment strategies have evolved with the aim of improving mucosal healing and the patient’s quality of life. Selection of the best treatment option is largely based on diagnosis, the site and severity of disease, and discussions with the patient. Since the disease is complex, long-term management involves collaboration between gastroenterologists, nurse specialists, dieticians and surgeons.
Education is essential to ensure that patients understand the importance of taking regular medication. Patients with UC failing to take regular aminosalicylate therapy are five times more likely to relapse, often requiring hospitalisation to treat complications; treatment of these patients costs the National Health Service in the UK 20 times more than patients in remission.
Effective management of IBD requires a holistic approach. The disease affects the lives of patients and their families in many ways; support and education provided by IBD nurses and other members of the multidisciplinary team helps to improve concordance with therapy and the likelihood of achieving favourable outcomes.
Job number: JB57410GBv Date of Preparation: August 2019
You must be registered to GutNews.org
to view or download these files
Brief report: length of ileal resection correlates with severity of bile acid malabsorption in Crohn’s disease
In patients with Crohn’s disease who had a prior surgical resection there was a modest correlation between the length of ileal resection and the severity of bile acid malabsorption (BAM), as defined by tauroselcholic (75selenium) acid (SeHCAT) retention values. Response to bile salt sequestrant therapy was not dependent on SeHCAT retention values.
Are you a healthcare professional?
This educational website is developed by GE Healthcare for educational purposes. The information contained within this website is intended for healthcare professionals. By entering this website you are confirming that you are a healthcare professional.
This link opens another website that is not under the review or control of GE Healthcare Ltd and, as such, the company does not endorse the content, its accuracy, or any practices or standards contained within it.